The FDA has warned that ketamine and compounded ketamine products aren’t approved to treat any psychiatric disorder. This suggests that they haven’t been established to become safe or helpful. In 2019, the FDA approved a nasal spray called esketamine (Spravato) that’s derived from ketamine for treatment-resistant depression, but only in selec